IMMIX BIOPHARMA, INC. Stock Issued During Period, Shares, New Issues
IMMIX BIOPHARMA, INC. (IMMX) reported Stock Issued During Period, Shares, New Issues of 5.00 million shares for the 0-month period ending 2023-03-22, per its 10-Q filed 2023-05-12.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2023-05-12
- 2023-03-22: Stock Issued During Period, Shares, New Issues 0 month 5.00M shares.
| Period end | Stock Issued During Period, Shares, New Issues 0 month |
|---|---|
| 2023-03-22 | 5.00M shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |